TFM
ALNY icon

TFC Financial Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

TFC Financial Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.7K Hold
72
– – ﹤0.01% 366
2026
Q1 		$23.8K Hold
72
– – ﹤0.01% 340
2025
Q4 		$28.6K Sell
72
-2
-3% -$885 ﹤0.01% 322
2025
Q3 		$33.7K Hold
74
– – ﹤0.01% 305
2025
Q2 		$24.1K Hold
74
– – ﹤0.01% 323
2025
Q1 		$20K Hold
74
– – ﹤0.01% 319
2024
Q4 		$17.4K Hold
74
– – ﹤0.01% 329
2024
Q3 		$20.4K Buy
74
+20
+37% +$5.21K ﹤0.01% 323
2024
Q2 		$13.1K Buy
54
+3
+6% +$474 ﹤0.01% 327
2024
Q1 		$7.62K Buy
51
+1
+2% +$167 ﹤0.01% 350
2023
Q4 		$9.57K Hold
50
– – ﹤0.01% 333
2023
Q3 		$8.86K Hold
50
– – ﹤0.01% 354
2023
Q2 		$9.5K Sell
50
-75
-60% -$14.9K ﹤0.01% 337
2023
Q1 		$25K Hold
125
– – 0.01% 291
2022
Q4 		$29.7K Hold
125
– – 0.01% 233
2022
Q3 		$25K Hold
125
– – 0.01% 237
2022
Q2 		$18K Hold
125
– – 0.01% 262
2022
Q1 		$20K Hold
125
– – 0.01% 254
2021
Q4 		$21K Hold
125
– – 0.01% 273
2021
Q3 		$24K Hold
125
– – 0.01% 254
2021
Q2 		$21K Hold
125
– – 0.01% 260
2021
Q1 		$18K Hold
125
– – 0.01% 262
2020
Q4 		$16K Hold
125
– – 0.01% 271
2020
Q3 		$18K Buy
+125
New +$17.8K 0.01% 240

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TFC Financial Management's ALNY Position: Q2 2026 in Review

TFC Financial Management held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 72 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #366.

TFC Financial Management first reported a position in ALNY in Q3 2020 and has held it in 24 quarters since. The position peaked at $33.7K in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • TFC Financial Management held 72 shares of Alnylam Pharmaceuticals worth $21.7K as of Q2 2026.
  • TFC Financial Management left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
  • Alnylam Pharmaceuticals made up ﹤0.01% of TFC Financial Management's portfolio in Q2 2026, its #366 holding.
  • TFC Financial Management first reported a position in Alnylam Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
  • TFC Financial Management's Alnylam Pharmaceuticals position peaked at $33.7K in Q3 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.